EQAS. Hemoglobin Program (BC80) Cycle 12: December 2014 December 2015 Sample No: 1 Sample Date: 17 Dec 14. Exceptions. Customer Information

Similar documents
Commentary by R. Little, Ph.D., NGSP Network Coordinator for the NGSP Steering Committee

Commentary by R. Little, Ph.D., NGSP Network Coordinator for the NGSP Steering Committee

College of American Pathologists (CAP) GH2 Survey Data: (updated 12/09) 2009 GH2-B (fresh pooled samples) * = NGSP certified at the time of the survey

State of the Art of HbA1c Measurement

Equalis user meeting Protein HbA1c the mean patient values might have been constant since 2007!

From Analytics to Action

Cancer Immunotherapy Pilot Program/ Patents 4 Patients. USPTO BCP Customer Partnership Meeting Alexandria, VA August 2, 2017

FGSZ Zrt. from 28 February 2019 till 29 February 2020 AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS

McLean ebasis plus TM

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Clinical outcomes of HbA1c standardisation

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Sleep Market Panel. Results for June 2015

Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers

Date : September Permit/License or Registration Application. Permit/License/ Notification/ Registration Description. Remark

Expression of HIV-1 Markers During Progression of Infection E E E Days Since 1st Bleed

18 Week 92% Open Pathway Recovery Plan and Backlog Clearance

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE

Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station

Timetable detailed schedule Term 3 and

Dementia Content Report January Produced By The NHS Choices Reporting Team

Dry Needling (DN) Registration

FAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)?

(a) y = 1.0x + 0.0; r = ; N = 60 (b) y = 1.0x + 0.0; r = ; N = Lot 1, Li-heparin whole blood, HbA1c (%)

Emergency Department Boarding of Psychiatric Patients in Oregon

FIELD SAFETY NOTICE (FSN) (Please refer to Annex 5 of the Guideline: MEDDEV REV.8 Guideline Vigilance)

Durham Region Influenza Bulletin: 2017/18 Influenza Season

Magellan s Transport Route Lead Monitoring Program

Evidence Based HbA1c Accuracy. Sabrina Koetsier Medical Scientist RCPAQAP Chemical Pathology

COURSE LISTING. Courses Listed. Training for Cloud with SAP Hybris in Service Cloud (C4C) 23 August 2018 (06:31 BST) Fortgeschrittene.

Curators of the University of Missouri - Combined January 01, 2013 through December 31, 2013 Cost Management Report

An Updated Approach to Colon Cancer Screening and Prevention

HIV-1 Seroconversion Panel PRB973

th Medical Group Report Card

Aina Blood Monitoring System

AccuVert HIV-1 Seroconversion Panel PRB974 ( )

Cincinnati Children s Hospital Medical Center PHO/OVPCA Constipation Initiative Monthly Report February 2018

Curators of the University of Missouri - Combined January 1, 2016 through December 31, 2016

STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS.

The CIDRZ Experience: use of data to understand patient outcomes and guide program implementation 07 January 2010

AccuVert HBV Seroconversion Panel PHM941(M) ( )

HIV-1 Seroconversion Panel

Regular Courses 2019

BREATH AND BLOOD ALCOHOL STATISTICS

HIV-1 Seroconversion Panel PRB975

Alcohol & Drugs. Contents:

Avian influenza in poultry, wild and captive birds (AI)

THE PORTUGUESE COMMUNITY SCREENING NETWORK

CryoSat-2 SARin mode over great rivers

Analysis of Meter Reading Validation Tolerances proposed by Project Nexus

What Computer Tools to Use for Your Quality and Safety Program

Regular Courses 2017

Quit Rates of New York State Smokers

City of Vancouver s Response to the Opioid Crisis Fire Chief Darrell Reid Vancouver Fire & Rescue Services (VF&RS)

Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD

Cost-Effectiveness of Lung Volume Reduction Surgery

Consultant-led Referral to Treatment (RTT) waiting times collection timetable: outcome of consultation

Review of Influenza Activity in San Diego County

Figure 1: Quantity Dispensed/100 Members (Ambien and Sonata on left axis)

Successful Falls Prevention in Aged Persons Mental Health. Reducing the risk and decreasing severity of outcome

Media kit. Highly Targeted Digital Marketing to Respiratory Care and Sleep Medicine Professionals

Saskatchewan HIV Strategy: Social Network Approach

Kansas EMS Naloxone (Narcan) Administration

Seasonality of influenza activity in Hong Kong and its association with meteorological variations

Dubrovnik 2014 Sverre Sandberg, Norwegian Quality Improvement of Primary Care Laboratories Noklus, Bergen, Norway

HIV-1 AccuVert TM Seroconversion Panel

ONLINE ACTIVITIES-BASED WELLNESS PROGRAM

Monitoring Protocol for Clozapine-induced Myocarditis. Copyright 2017, CAMH

June 28, 2008 General Assembly, Fort Lauderdale Presented by Linda Laskowski Unitarian Universalist Church of Berkeley

The Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England

Texas Vendor Drug Program Specialty Drug List Process. February 2019

Hand, Foot, and Mouth Disease Situation Update. Hand, Foot, and Mouth Disease surveillance summary

Bio-Rad Laboratories. Hemoglobin Testing. VARIANT II Hemoglobin Testing System For HbA 1c

Clostridium difficile (C. difficile) and Staphylococcus aureus bacteraemia (MRSA and MSSA) Bi-annual Report. Surveillance: Report:

Blood Alcohol Levels for Fatally Injured Drivers

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

BJA Performance Measures

Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting

Energy efficiency and renewable options for dairy farms

Weekly Influenza News 2016/17 Season. Communicable Disease Surveillance Unit. Summary of Influenza Activity in Toronto for Week 43

The Greater Manchester Stroke Operational Delivery Network

Marketing on a Budget: Monthly quit & win challenges to drive quitline utilization. Presenters: John Atkinson & Elizabeth Harvey

Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,

Sexual Health Content Report June Produced By The NHS Choices Reporting Team

Should HbA1C measured by POC instruments be used for diagnosis of diabetes? Sverre Sandberg, Norwegian Quality Improvement of Primary Care

Sample UC Irvine Medical Dosimetry Program Official Transcript

100 Abbott Park Road Abbott Park, IL Trade Name: ARCHITECT HIV Ag/Ab Combo Assay Approved Date: 18-JUN-2010

The PROMs Programme in the NHS in England

Crisis Connections Crisis Line Phone Worker Training (Online/Onsite) Winter 2019

Diabetes Education Programs

Discover the connection

Dementia Content Report May Produced By The NHS Choices Reporting Team

Tri-County Opioid Safety Coalition Data Brief December 2017 Clackamas, Multnomah, and Washington Counties

IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE. A Clinical Quality Improvement Program

Insulin Administration Errors in Adult Community Nursing. Hedy Lehman Assistant Director of Professional Standards, Adult Community Nursing

BLOOD ALCOHOL LEVELS FOR FATALLY INJURED DRIVERS

CONTROL CHART METHODOLOGY

Monitoring Metastatic Breast Cancer with Serum HER-2/neu: Individual Patient Profiles

INFLUENZA IN MANITOBA 2010/2011 SEASON. Cases reported up to January 29, 2011

Education around PML risk and monitoring at NHNN Queen Square MS Centre

Transcription:

(BC80) : December 2014 December 20 Exceptions None at this time. Legend: No Warnings Missing Result Late Results < < > * Amended Result (per participant s request) News Customer Information Please refer to QCNet > > Unity/ Bulletin for important coding and instrument specific information. The bulletin is published on a monthly basis and should be viewed regularly. RMV = Reference Method Value Hemoglobin A1c: Sample 1 (NGSP %) 5.2 Sample 1 (IFCC mmol/mol) 33.5 Lab: 008323 Attn: MS. MUKTA SEHGAL QA Bio Rad Laboratories is accredited to ISO/IEC 043:2010. Refer to the User Guide for additional information on the Program, reports, their interpretation, statistics, and contact details. is a trademark of Bio Rad Laboratories, Inc. Page 1 of 6

Configuration Report Selected Options: Data Input: Report Receipt: Subgroup Number: Online QCNet None Instrument 2749 Analyte Method Reagent Unit 289 A1C N 022 0662 HbA1c (220 0101) 93 % Instrument 0900 Analyte Method Reagent Unit 282 A2 022 0006 93 % is a trademark of Bio Rad Laboratories, Inc. Page 2 of 6

Sample Summary Report Instrument: Analyte Unit Result Mean RMZ Comparator Hemoglobin A1c (NGSP) % 5.38 0.14 0. Peer Instrument: Analyte Unit Result Mean RMZ Comparator Hemoglobin A2 % 2.4 2.56 0.77 0.49 Peer Legend: No Warnings Missing Result Late Results < < > * Amended Result (per participant s request) Non robust determination of Mean and SD Problem Classification: Corrective Action: Reviewed by: is a trademark of Bio Rad Laboratories, Inc. Page 3 of 6 Date:

Hemoglobin A1c (NGSP) Report % Comparative Statistics Your Deviation N Mean SD CV U¹ RMZ % Your Mode 673 5.37 0.2 2.83 0. 7 0.545 Your Method 504 5.36 0.137 2.55 0.26 0. 0.668 Your Peer 9 5.38 0.140 2.61 27 0.14 0. 0.372 PEER DISTRIBUTION 49 METHOD DISTRIBUTION 140 MODE DISTRIBUTION 8 Date Target 4.68 6.08 6.6 8.4 6.6 9.6 21 18 Jan 14 Feb 14 Mar 14 Apr 14 May 14 Jun 14 Jul 14 Aug 14 Sep 14 Oct 14 Nov 14 Dec 14 4.68 6.05 6.6 8.3 9.6 6.6 8.3 20 8.3 9.6 4.61 6.13 N Mean CV U¹ HbA1c (220 0101) 9 5.38 2.61 27 120 5.37 2.84 35 TURBO Bio Rad VARIANTII TURBO A1c (270 2455/EX) 60 5.36 2. 37 Dual HbA1c/A2/F (220 0201) 50 5.35 2.35 45 Roche cobas INTEGRA Immunoturbidimetric 22 5.32 2.77 79 TURBO 21 6 1.89 56 Tosoh G7/G8 Series 21 5.35 2.48 72 Siemens DCA 2000 Immunoturbidimetric 5.61 2.85 97 Dual HbA1c/A2/F (270 2500) 14 5.22 2.79 97 CYCLE Hemoglobin A1c (NGSP) 12 : SAMPLE 1 is a trademark of Bio Rad Laboratories, Inc. Page 4 of 6

Hemoglobin A2 Report 2.4 % Comparative Statistics Your Deviation N Mean SD CV U¹ RMZ % All Results 201 2.43 0.299 12.3 53 9 0.35 5 Your Method 180 2.44 0.293 1 55 0.13 0.42 1.60 Your Peer 20 2.56 0.202 7.92 0.113 0.77 0.49 6.13 PEER DISTRIBUTION 5 METHOD DISTRIBUTION 27 MODE DISTRIBUTION 33 1.80 2.80 0.976 3.90 0.932 3.92 Date Target 3.3 3.6 2.4 3.3 2.4 21 2.4 18 Jan 14 Feb 14 Mar 14 Apr 14 May 14 Jun 14 Jul 14 Aug 14 Sep 14 Oct 14 Nov 14 Dec 14 3.3 3.6 20 2.5 3.6 2.5 2.6 2.4 3.3 3.6 N Mean CV U¹ Dual HbA1c/A2/F (220 0201) 55 2.30 1 0.101 Beta Thal Short (270 2103/... 37 2.41 6.42 64 Dual HbA1c/A2/F (270 2500) 23 2.91 8.70 0.132 20 2.56 7.92 0.113 14 2.29 6.97 0.107 Bio Rad VARIANT 10 2.51 8.64 0.1 Sebia Electrophoresis 6 2. 4.40 96 Tosoh G7/G8 Series 4 6 6.67 0.2 Sebia CAPILLARYS Electrophoresis 4 2.25 6.51 0.183 CYCLE Hemoglobin A2 12 : SAMPLE 1 is a trademark of Bio Rad Laboratories, Inc. Page 5 of 6

Data on File Report Sample Numbers Analyte Unit 1 2 3 4 5 6 7 8 9 10 11 12 Instrument: A1C N % Instrument: A2 % 2.4 Legend: No Warnings Late Results < < > No Result * Amended Result (per participant s request) is a trademark of Bio Rad Laboratories, Inc. Page 6 of 6

Certificate of Registration THIS IS TO CERTIFY THAT: QA HAS REGISTERED TO PARTICIPATE IN EXTERNAL QUALITY ASSESSMENT FOR: : December 2014 December 20 FOR THE FOLLOWING TESTS: Hemoglobin A1c (NGSP) Hemoglobin A2 This certificate is not intended to imply acceptable performance in the above program, only to suggest that participation will be in effect during the stated time. Date of Enrollment 11 December 2014 Bio Rad Laboratories is fully accredited by the American Association for Laboratory Accreditation (A2LA) to the ISO/IEC 043:2010 standard. Kandy Cendejas Kandy Cendejas, Program Manager Bio-Rad Laboratories Program Enrollment 9500 Jeronimo Road Irvine, CA 92618 20, USA email: eqas@bio rad.com is a trademark of Bio Rad Laboratories, Inc.